MedTrace Logo

Effect of New Specialized Technique Using Effleurage Massage on Striae Gravidarum

NCT07265440 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2025-12-04

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if our new specialized technique using effleurage massage works to prevent striae gravidarum in primigravida. The main questions it aims to answer are:

Can our new specialized technique using effleurage massage prevent or even decrease the severity of striae gravidarum in primigravida ? What side effects may participants face when using our technique?

Participants will:

perform effleurage massage in transverse direction from medial to lateral only not back and forth, twice a day starting from the 17th week until the 28th week of pregnancy and three times a day starting from the 28th week of pregnancy for 10 minutes for each time until date of birth but from lateral to medial. It will be performed on the whole abdominal area extending from the diaphragm to the pupic area, also on both sides of the abdomen extending from the 12th rib to the iliac crest.

Conditions

  • Striae Gravidarum

Interventions

OTHER

New specialized technique using effleurage massage

effleurage massage was performed in transverse direction from medial to lateral only not back and forth, twice a day starting from the 17th week until the 28th week of pregnancy and three times a day starting from the 28th week of pregnancy for 10 minutes for each time until date of birth but from lateral to medial. It will be performed on the whole abdominal area extending from the diaphragm to the pupic area, also on both sides of the abdomen extending from the 12th rib to the iliac crest.

Sponsors & Collaborators

  • Kafrelsheikh University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
30 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-09
Primary Completion
2025-01-12
Completion
2025-05-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07265440 on ClinicalTrials.gov